Sort
23,748 grants matching “melanoma”
Novel Biosynthetic Pathway for Secosteroids and the Skin
$376,757Andrzej T Slominski · University Of Tennessee Health Sci Ctr · R01 · FY2010 · AR
Role of Sirt2 in T Cell Metabolism
$376,751Sungjune Kim · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2021 · CA
Druggable Genetic Lesions in Pediatric Astrocytoma
$376,751William C Hahn · Dana-Farber Cancer Inst · P01 · FY2012 · CA
Characterizing oncogenic function of ITCH in melanoma
$376,751Lixin Wan · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
Role of Sirt2 in T Cell Metabolism
$376,751Sungjune Kim · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2022 · CA
Mechanism of Retinal Damage in Autoimmune Retinopathy
$376,711Grazyna Adamus · Oregon Health & Science University · R01 · FY2007 · EY
Follicular Regulatory T-cells Promote Cancer
$376,659Jianmei Wu Leavenworth · University Of Alabama At Birmingham · R01 · FY2024 · CA
Angiogenic Factors Associated with Uveal Melanoma
$376,608Arthur S Polans · University Of Wisconsin-Madison · R01 · FY2007 · CA
Preclinical Study of Peptide Based Human Tumor Vaccines
$376,597University Of Virginia Charlottesville · R01 · FY2004 · CA
Lymph Node Alterations in Cancer
$376,557M Alanna Ruddell · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
Actively engaging NK cells during virotherapy to induce neoantigen-specific antitumor immunity
$376,557Xiaoliu Zhang · University Of Houston · R01 · FY2023 · CA
Optimizing Response to Immune Checkpoint Inhibitor Therapy for Breast Cancer: A Role for Inhibitors of the PI3K pathway
$376,492Ann Richmond · Vanderbilt University · R01 · FY2020 · CA
Project 2: Mechanochemical Mechanisms and Vulnerabilities of Individual and Collective Organ-Preferential Metastasis In Vivo
$376,488Peter Friedl · Massachusetts Institute Of Technology · U54 · FY2021 · CA
Statistical Methods for Population Genomics and "Next-gen" Sequencing Data
$376,477Paul A Scheet · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · HG
STING Activating Synthetic Nanovaccine for HPV-Induced Cancers
$376,428Jinming Gao · Ut Southwestern Medical Center · R01 · FY2020 · CA
STING Activating Synthetic Nanovaccine for HPV-Induced Cancers
$376,428Jinming Gao · Ut Southwestern Medical Center · R01 · FY2021 · CA
STING Activating Synthetic Nanovaccine for HPV-Induced Cancers
$376,428Jinming Gao · Ut Southwestern Medical Center · R01 · FY2018 · CA
PAX3 pathways in melanoma
$376,389Deborah Lang · Boston University Medical Campus · R01 · FY2017 · CA
Targeting BRAF and MEK in tumors with BRAF and RAS mutations.
$376,384David B. Solit · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
Targeting BRAF and MEK in tumors with BRAF and RAS mutations.
$376,384David B. Solit · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA
Therapeutic Targeting of Receptor Tyrosine Kinase Hierarchies in Schwann Cell Neoplasms
$376,348Steven L Carroll · Medical University Of South Carolina · R01 · FY2021 · NS
Restoration of Tumor Suppression Activity in Malignant Melanoma
$376,297David Joseph Weber · University Of Maryland Baltimore · R01 · FY2009 · CA
Molecular connections among UV exposure, red hair, nevi and melanoma
$376,294Rutao Cui · Boston University Medical Campus · R01 · FY2017 · CA
Role of CDK4 in Cell Cycle Progression and Cancer
$376,250Temple University · R01 · FY2002 · AG
Uncover the new subsets of epidermal Langerhans cells
$376,250Qing-Sheng Mi · Henry Ford Health System · R61 · FY2019 · AR